Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report

Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report

Abstract Background Anti-Myelin oligodendrocyte glycoprotein (MOG) antibodies are detected in various demyelinating diseases, such as pediatric acute disseminated encephalomyelitis (ADEM), recurrent optic neuritis, and aquaporin-4 antibody-seronegative neuromyelitis optica spectrum disorder. We pres...

Full description

Bibliographic Details
Main Authors:	Yoshitsugu Nakamura, Hideto Nakajima, Hiroki Tani, Takafumi Hosokawa, Shimon Ishida, Fumiharu Kimura, Kimihiko Kaneko, Toshiyuki Takahashi, Ichiro Nakashima
Format:	Article
Language:	English
Published:	BMC 2017-04-01
Series:	BMC Neurology
Subjects:	Myelin oligodendrocyte glycoprotein Acute disseminate encephalomyelitis Epstein–Barr virus Transverse myelitis Antecedent infection Case report
Online Access:	http://link.springer.com/article/10.1186/s12883-017-0858-6

Similar Items

MRI-negative myelitis associated with MOG-IgG antibody: A case report and literature reviews
by: Jiwon Yang, et al.
Published: (2023-12-01)

Acute Hemorrhagic Encephalomyelitis in the Context of MOG Antibody-Associated Disease. Comment on Chen et al. Rapid Progressive Fatal Acute Hemorrhagic Encephalomyelitis. <i>Diagnostics</i> 2023, <i>13</i>, 2481
by: Sohyeon Kim, et al.
Published: (2023-10-01)

Clinical, radiological, therapeutic and prognostic differences between MOG-seropositive and MOG-seronegative pediatric acute disseminated encephalomyelitis patients: a retrospective cohort study
by: Xueshan Dong, et al.
Published: (2023-05-01)

MOG antibody-associated disease – a new entity or one of the forms of the NMO spectrum?
by: Dominika Czarnecka, et al.
Published: (2019-10-01)

Response Surface Methodology Approach to Optimize the Expression of Thioredoxin-MOG Fusion Protein
by: Maryam Radmard, et al.
Published: (2024-04-01)

Spinal Cord Involvement in MS and Other Demyelinating Diseases
by: Mariano Marrodan, et al.
Published: (2020-05-01)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
by: Erica Parrotta, et al.
Published: (2020-09-01)

Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
by: Gina Perez-Giraldo, et al.
Published: (2023-07-01)

Clinical characteristics and associated factors of pediatric acute disseminated encephalomyelitis patients with MOG antibodies: a retrospective study in Hangzhou, China
by: Jue Shen, et al.
Published: (2022-11-01)

Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders
by: Masoud Etemadifar, et al.
Published: (2017-10-01)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
by: Sven Jarius, et al.
Published: (2020-09-01)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Min Zhang, et al.
Published: (2020-11-01)

Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis
by: Yuanhua Cai, et al.
Published: (2022-10-01)

A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion
by: Florent Salvador, et al.
Published: (2022-02-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease manifesting as intractable fever managed by bromocriptine: a case report
by: Jin San Lee, et al.
Published: (2023-06-01)

Recurrent myelin oligodendrocyte glycoprotein⁃IgG⁃associated optic neuritis⁃encephalomyelitis: one case report
by: Jing SHA, et al.
Published: (2020-10-01)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
by: Sven Jarius, et al.
Published: (2020-09-01)

Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells
by: Maryam J. Tavaf, et al.
Published: (2023-01-01)

Is aberrant N-glucosylation relevant to recognise anti-MOG antibodies in Rett syndrome?
by: Feliciana Real-Fernández, et al.
Published: (2019-10-01)

Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
by: Renata Barbosa Paolilo, et al.
Published: (2023-02-01)

Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis
by: Mehrdad Gholamzad, et al.
Published: (2021-06-01)

Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses
by: Dariush Haghmorad, et al.
Published: (2022-11-01)

The Wide Variety of Acute Disseminated Encephalomyelitis in Children: A Clinical Perspective
by: Hyunsuk Lim, et al.
Published: (2022-10-01)

MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
by: Sara Mariotto, et al.
Published: (2017-10-01)

Unraveling Myelin Plasticity
by: Giulia Bonetto, et al.
Published: (2020-06-01)

Case Series: Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Related Disease Spectrum
by: Foziah Alshamrani, et al.
Published: (2020-02-01)

The MOG antibody associated encephalitis preceded by COVID-19 infection; a case study and systematic review of the literature
by: Michał Borończyk, et al.
Published: (2023-08-01)

The organization of microtubules and Tau in oligodendrocytes: Tau pathology in damaged oligodendrocytes
by: Tomohiro Torii, et al.
Published: (2022-10-01)

Mechanisms Governing Oligodendrocyte Viability in Multiple Sclerosis and Its Animal Models
by: Zhixin Lei, et al.
Published: (2024-01-01)

Myelin oligodendrocyte glycoprotein encephalomyelitis: An unusual cause of blindness
by: Nimrat Sandhu, et al.
Published: (2022-01-01)

Radiological Features for Outcomes of MOGAD in Children: A Cohort in Southwest China
by: Fan X, et al.
Published: (2022-08-01)

Transient myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis following influenza A infection: A rare case
by: Prashant Nasa, et al.
Published: (2021-01-01)

Anti-MOG associated myelitis
by: A. I. Isaykin, et al.
Published: (2020-06-01)

From OPC to Oligodendrocyte: An Epigenetic Journey
by: Assia Tiane, et al.
Published: (2019-10-01)

Endothelin signalling mediates experience-dependent myelination in the CNS
by: Matthew Swire, et al.
Published: (2019-10-01)

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery
by: Feng Mei, et al.
Published: (2016-09-01)

Phenotypic Characteristics and Recurrence Factors of MOG-IgG Associated Disorders in Children
by: WANG Xin, ZHAO Ruibin, YANG Huafang, LIU Chong, LIU Tian, LU Cui, CHEN Didi
Published: (2023-06-01)

Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
by: Shambaditya Das, et al.
Published: (2023-03-01)

Lower motor neuron paralysis with extensive cord atrophy in parainfectious acute transverse myelitis
by: Sunil Pradhan, et al.
Published: (2014-01-01)

Myelin oligodendrocyte glycoprotein (MOG) associated optic neuritis in a patient with idiopathic intracranial hypertension (IIH) and compressive optic neuropathy case report
by: Ryan D. Sorensen, et al.
Published: (2024-02-01)